-
Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide
in Uncategorized onFerring Pharmaceuticals announced today the commencement of the Phase 3b PRONOUNCE Trial. The trial will compare the occurrence of major…
0 -
Ferring Pharmaceuticals and Karolinska Institutet sign collaboration agreement on the development of a Human Microbiome Translational Research Programme
in Uncategorized onFerring Pharmaceuticals and Karolinska Institutet announce today that a collaboration agreement has been signed for the establishment of a…
-
Targeted Immuno Therapies AB and Ferring Pharmaceuticals sign a strategic collaboration agreement for the treatment of IBD
in Uncategorized onTargeted Immuno Therapies (TLA) announced today that it has signed a strategic collaboration agreement with Ferring Pharmaceuticals…
-
Cosmo & Ferring Pharmaceuticals enter into licensing agreement for CORTIMENT®MMX® (budesonide) in Japan
in Uncategorized onCosmo Pharmaceuticals S.A. (SIX: COPN) announced today that it has signed a licensing agreement with Ferring Pharmaceuticals…
-
Ferring Pharmaceuticals submits variation application to introduce new tailored dosing regimen in the PICOPREP® (sodium picosulfate, magnesium oxide, citric acid) label
in Uncategorized onFerring Pharmaceuticals announced today that it has submitted a variation application in the Mutual Recognition…
-
Ferring receives acceptance of Marketing Authorisation filing from EMA for personalised fertility treatment with REKOVELLE® (follitropin delta)
in Uncategorized onFerring Pharmaceuticals announced today that the filing for the Marketing Authorisation Application for…
-
Ferring Pharmaceuticals acquires global rights to MILPROSA (progesterone vaginal ring)
in Uncategorized onFerring Pharmaceuticals announced today that it has acquired the global rights to MILPROSATM (progesterone vaginal ring) from Teva Women’s…
-
Ferring Pharmaceuticals begins Phase 2b/3 trial of selepressin for treatment of septic shock
in Uncategorized onFerring Pharmaceuticals announced initiation of patient enrollment in a phase 2b/3 clinical trial of selepressin for the treatment of septic shock…
-
Ferring Pharmaceuticals moves forward with early stage development of bacteriophage therapy for inflammatory bowel disease
in Uncategorized onFerring Pharmaceuticals announced today that it will collaborate with Baltimore-based Intralytix, Inc…
-
Inflammatory Bowel Disease Treatment Gets Boost From New Educational Resource
in Uncategorized onA new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD)…
Author archive for pulse
Articles by: pulse